KLCM
ELV icon

KG&L Capital Management’s Elevance Health ELV Stock Holding History

KG&L Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,510
Closed -$785K – 191
2024
Q3 		$785K Buy
1,510
+42
+3% +$22.4K 0.25% 86
2024
Q2 		$795K Buy
1,468
+145
+11% +$76.6K 0.28% 80
2024
Q1 		$686K Buy
1,323
+312
+31% +$155K 0.27% 76
2023
Q4 		$477K Buy
+1,011
New +$467K 0.2% 101

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

KG&L Capital Management's ELV Position: Q4 2024 in Review

KG&L Capital Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 1,510 shares — an estimated $785K sold.

KG&L Capital Management first reported a position in ELV in Q4 2023 and held it in 4 quarters. The position peaked at $795K in Q2 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • KG&L Capital Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • KG&L Capital Management sold 1,510 Elevance Health shares in Q4 2024, an estimated $785K.
  • KG&L Capital Management first reported a position in Elevance Health in Q4 2023 and held it in 4 quarters.
  • KG&L Capital Management's Elevance Health position peaked at $795K in Q2 2024.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on KG&L Capital Management's 13F filing for Q4 2024, filed 24 Jan 2025.